283 related articles for article (PubMed ID: 22810901)
1. Refractory celiac disease: from bench to bedside.
Malamut G; Meresse B; Cellier C; Cerf-Bensussan N
Semin Immunopathol; 2012 Jul; 34(4):601-13. PubMed ID: 22810901
[TBL] [Abstract][Full Text] [Related]
2. Monitoring nonresponsive patients who have celiac disease.
Krauss N; Schuppan D
Gastrointest Endosc Clin N Am; 2006 Apr; 16(2):317-27. PubMed ID: 16644460
[TBL] [Abstract][Full Text] [Related]
3. Refractory coeliac disease.
Malamut G; Cellier C
Curr Opin Oncol; 2013 Sep; 25(5):445-51. PubMed ID: 23942290
[TBL] [Abstract][Full Text] [Related]
4. Refractory Celiac Disease.
Malamut G; Cellier C
Gastroenterol Clin North Am; 2019 Mar; 48(1):137-144. PubMed ID: 30711206
[TBL] [Abstract][Full Text] [Related]
5. Classification and management of refractory coeliac disease.
Rubio-Tapia A; Murray JA
Gut; 2010 Apr; 59(4):547-57. PubMed ID: 20332526
[TBL] [Abstract][Full Text] [Related]
6. Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype.
de Mascarel A; Belleannée G; Stanislas S; Merlio C; Parrens M; Laharie D; Dubus P; Merlio JP
Am J Surg Pathol; 2008 May; 32(5):744-51. PubMed ID: 18360280
[TBL] [Abstract][Full Text] [Related]
7. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization.
Verbeek WH; von Blomberg BM; Coupe VM; Daum S; Mulder CJ; Schreurs MW
Cytometry B Clin Cytom; 2009 Nov; 76(6):367-74. PubMed ID: 19444812
[TBL] [Abstract][Full Text] [Related]
8. Refractory celiac disease.
Malamut G; Murray JA; Cellier C
Gastrointest Endosc Clin N Am; 2012 Oct; 22(4):759-72. PubMed ID: 23083992
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells promote expansion and survival of aberrant TCR-negative intraepithelial lymphocyte lines from refractory celiac disease type II patients.
Schmitz F; Tjon JM; van Bergen J; Koning F
Mol Immunol; 2014 Mar; 58(1):10-6. PubMed ID: 24252355
[TBL] [Abstract][Full Text] [Related]
10. The Intracellular Intensity of CD3 on Aberrant Intraepithelial Lymphocytes Is a Prognostic Factor of the Progression to Overt Lymphoma in Refractory Celiac Disease Type II (Pre-Enteropathy-Associated T Cell Lymphoma).
García-Hoz C; Crespo L; Lopez N; De Andrés A; Ríos León R; Santón A; Garriga M; Butz E; León F; Roy Ariño G
Dig Dis; 2020; 38(6):490-499. PubMed ID: 32015237
[TBL] [Abstract][Full Text] [Related]
11. Update on the diagnosis and management of refractory coeliac disease.
Nijeboer P; van Wanrooij RL; Tack GJ; Mulder CJ; Bouma G
Gastroenterol Res Pract; 2013; 2013():518483. PubMed ID: 23762036
[TBL] [Abstract][Full Text] [Related]
12. Recognising and Managing Refractory Coeliac Disease: A Tertiary Centre Experience.
Nasr I; Nasr I; Beyers C; Chang F; Donnelly S; Ciclitira PJ
Nutrients; 2015 Dec; 7(12):9896-907. PubMed ID: 26633478
[TBL] [Abstract][Full Text] [Related]
13. Refractory celiac disease: epidemiology and clinical manifestations.
Malamut G; Cellier C
Dig Dis; 2015; 33(2):221-226. PubMed ID: 25925926
[TBL] [Abstract][Full Text] [Related]
14. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group.
Cellier C; Delabesse E; Helmer C; Patey N; Matuchansky C; Jabri B; Macintyre E; Cerf-Bensussan N; Brousse N
Lancet; 2000 Jul; 356(9225):203-8. PubMed ID: 10963198
[TBL] [Abstract][Full Text] [Related]
15. The management of complicated celiac disease.
Al-toma A; Verbeek WH; Mulder CJ
Dig Dis; 2007; 25(3):230-6. PubMed ID: 17827946
[TBL] [Abstract][Full Text] [Related]
16. Refractory celiac disease.
Malamut G; Cellier C
Expert Rev Gastroenterol Hepatol; 2014 Mar; 8(3):323-8. PubMed ID: 24502536
[TBL] [Abstract][Full Text] [Related]
17. AGA Clinical Practice Update on Management of Refractory Celiac Disease: Expert Review.
Green PHR; Paski S; Ko CW; Rubio-Tapia A
Gastroenterology; 2022 Nov; 163(5):1461-1469. PubMed ID: 36137844
[TBL] [Abstract][Full Text] [Related]
18. T-cell repertoires in refractory coeliac disease.
Ritter J; Zimmermann K; Jöhrens K; Mende S; Seegebarth A; Siegmund B; Hennig S; Todorova K; Rosenwald A; Daum S; Hummel M; Schumann M
Gut; 2018 Apr; 67(4):644-653. PubMed ID: 28188172
[TBL] [Abstract][Full Text] [Related]
19. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II.
Malamut G; Afchain P; Verkarre V; Lecomte T; Amiot A; Damotte D; Bouhnik Y; Colombel JF; Delchier JC; Allez M; Cosnes J; Lavergne-Slove A; Meresse B; Trinquart L; Macintyre E; Radford-Weiss I; Hermine O; Brousse N; Cerf-Bensussan N; Cellier C
Gastroenterology; 2009 Jan; 136(1):81-90. PubMed ID: 19014942
[TBL] [Abstract][Full Text] [Related]
20. Refractory coeliac disease.
Daum S; Cellier C; Mulder CJ
Best Pract Res Clin Gastroenterol; 2005 Jun; 19(3):413-24. PubMed ID: 15925846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]